Day February 25, 2026
HMN 2026: How Engineered immune cells help reduce toxic proteins in the brain
HMN 2026: How Immune cells from pediatricians help uncover an antibody cocktail against RSV and hMPV
HMN 2026: How immune cells in the adult brain can regulate generation of new neurons
HMN 2026: How IGF speeds lymphatic vessel growth, hinting at new lymphedema therapy
HMN 2026: How IBD study tracks 54,000 patients, links dysplasia grade to cancer risk
Low magnification micrograph of a tubulovillous adenoma, TVA. Credit: Nephron, Wikimedia/CC BY-SA 3.0 Precancerous colorectal lesions, or dysplasia, in patients with inflammatory bowel disease (IBD) confer markedly different risks of future colorectal cancer depending on dysplasia grade, according to a…
HMN 2026: How Hydrogen-bond networks boost all-perovskite solar cell efficiency
HMN 2026: How Post-hurricane heat can overwhelm first responders during prolonged outages
HMN 2026: How Two key tags guide their disposal
HMN 2026: How Huntington’s disease offers a rare clean test case for brain research
HMN 2026: How did humans develop sharp vision? Lab-grown retinas show likely answer
HMN 2026: How Replacing humans with machines is leaving truckloads of food stranded and unusable
HMN 2026: What a new walking algorithm changes
HMN 2026: What makes us human? A unique brain perspective in new book
HMN 2026: How Human stem cell lines offer new resource to help study HIV progression
HMN 2026: How to Teach the human skills AI can’t replace
HMN 2026: How Human mesenchymal stem cells show promise in treating neonatal brain damage, paving way for stem cell trials
An outline of our optimised high throughput in vivo screening protocol for determining the ideal treatment paradigm for human umbilical cord-derived MSCs (HuMSCs) in two rat models of perinatal brain injury: inflammation-induced encephalopathy of prematurity (EoP, via intraperitoneal IL-1? injection)…
HMN 2026: How novel immune cell therapy is safe and effective in advanced lymphoma
HMN 2026: How HPV cancer vaccine slows tumor growth and extends survival in preclinical model
HMN 2026: How microbes live with ‘us?’
HMN 2026: How Household cat could hold the key to understanding breast cancer
HMN 2026: What is this German habit and is it good for your health?
HMN 2026: What ‘housane’ rings are and why a light-powered route may matter for drugs
HMN 2026: How Working hours are reduced or jobs abandoned by one in five tinnitus patients
HMN 2026: How Will drinking hot water help me lose weight, clear my skin or treat cramps?
HMN 2026: What is the cooling coating that can also reduce fire risk
The coating’s improved performance comes from the dendritic structure creating more interfaces, which scatter sunlight more effectively and increase reflectivity. Credit: IMDEA Materials Institute An international research team has demonstrated how conventional radiative cooling coatings can be optimized to further…
HMN 2026: How Hospitals with advanced IT and trial participation cut COVID-19 mortality faster
HMN 2026: How Existing hospital analyzers offer a low-cost method to screen for fake vaccines
The four stages used in this study to evaluate the biochemical profiling method to differentiate genuine vaccines and insulin from falsified surrogates. Credit: Scientific Reports (2026). DOI: 10.1038/s41598-026-37281-9 The World Health Organization (WHO) estimates that 10.5% of medicines worldwide in…
HMN 2026: How Hospice use after ICU admission increased across the US from 2011–2023
HMN 2026: How Home visit program leads to sixfold increase in early childhood vaccines
HMN 2026: How Maps can encourage home radon testing in the right settings
HMN 2026: What is the Dutch model that challenges bureaucracy
HMN 2026: How HIV entry blocker pairs CD4 mimic and antibody, showing sevenfold higher efficacy
HMN 2026: How HIV antibody opens up new approaches for vaccine development and combination therapies
Potent neutralizing activity requires 007 bivalency. Credit: Nature Immunology (2026). DOI: 10.1038/s41590-025-02385-3 An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study,…
